Skip to main content
SpringerLink
Log in

The Treatment of Metabolic Bone Diseases

  • Practical Therapeutic
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bijvoet, O.L.M.; Hosking, D.J.; Van Aken, J. and Will, E.J.: The treatment of Paget’s disease. Combination of calcitonin and diphosphonate; in Kanis (Ed.) Bone Disease and Calcitonin, pp. 25–26 (Armour Pharmaceutical Company, Eastbourne, 1977).

    Google Scholar 

  • Evans, R.A.: A cheap oral therapy for Paget’s disease of bone. Calcified Tissue Research 22 (Suppl.): 287–295 (1977).

    Article  PubMed  Google Scholar 

  • Ingham, J.P.: Anticonvulsants and bone. Current Therapeutics 17(2): 13–16 (Feb. 1976).

    Google Scholar 

  • Ingham, J.P.: Osteoporosis: Diagnosis and treatment. Drugs 8: 290–306 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Mason, R.S. and Posen, S.: Some problems associated with assay of 25-hydroxycalciferol in human serum. Clinical Chemistry 23: 808–810 (1977).

    Google Scholar 

  • Mason, R.S. and Posen, S.: The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism. Clinical Endocrinology (In press, 1979).

  • Mason, R.S., Modell, D.; McElduff, A.; Stewart, J.; Mahony, J. and Posen, S.: The relevance of 25-hydroxycalciferol measurements in sera of patients with renal failure. Australian and New Zealand Journal of Medicine (In press, 1979).

  • Meema, S.; Bunker, M.L. and Meema, H.E.: Preventive effect of estrogen on postmenopausal bone loss. Archives of Internal Medicine 135: 1436–1440 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Plehwe, W.E.; Hudson, J.; Clifton-Bligh, P. and Posen, S.: Porcine calcitonin in the treatment of Paget’s disease of bone. Experiences with 32 patients. Medical Journal of Australia 1: 577–581 (1977).

    PubMed  CAS  Google Scholar 

  • Posen, S.; Lee, C.; Vines, R.; Kilham, H.; Latham, S. and Keefe, J.F.: Transient hyperphosphatasemia of infancy — an insufficiently recognised syndrome. Clinical Chemistry 23: 292–294 (1977).

    PubMed  CAS  Google Scholar 

  • Rebel, A.; Malkani, K.; Basle, M. and Bregeon, C.: Osteoclast ultrastructure in Paget’s disease. Calcified Tissue Research 20: 187–199 (1976).

    Article  Google Scholar 

  • Recker, R.R.; Saville, P.D. and Heaney, R.P.: Effect of estrogens and calcium carbonate on bone loss in post-menopausal women. Annals of Internal Medicine 87: 649–655 (1977).

    PubMed  CAS  Google Scholar 

  • Rosenbaum, H.D. and Hanson, D.J.: Geographic variation in the prevalence of Paget’s disease of bone. Radiology 92: 959–963 (1969).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sydney Hospital, G.P.O. Box 1614, Sydney, NSW, 2001, Australia

    S. Posen,  P. Clifton-Bligh &  R. S. Mason

Authors
  1. S. Posen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Clifton-Bligh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. S. Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Presented in part as a symposium to the Eastern SuburbsMedical Association, Sydney, September 20, 1978

Rights and permissions

Reprints and permissions

About this article

Cite this article

Posen, S., Clifton-Bligh, P. & Mason, R.S. The Treatment of Metabolic Bone Diseases. Drugs 17, 297–302 (1979). https://doi.org/10.2165/00003495-197917040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197917040-00004

Keywords

Search

Navigation